Background
Wearable technologies are used in sport to monitor training load, biomechanics, physiology, and recovery, but their effectiveness in injury prevention remains uncertain.
Aim
To evaluate evidence on wearables for sports injury prevention using a framework covering measurement validity, injury association, prognostic modelling, implementation, and intervention effectiveness.
Material and methods
A narrative review of wearables monitoring modifiable injury-related factors was conducted. Findings were organized across five translational levels, from measurement validity to injury reduction, following SANRA recommendations [20].
Results
Validity and reliability depend on the device, algorithm, sensor placement, and sporting task. Associations between wearable-derived metrics and injuries are inconsistent and do not support universal risk thresholds. Machine-learning models show promise, but their use is limited by poor external validation, calibration, and methods. Implementation, organizational context, and human decision-making affect practical value. Direct evidence that wearable-guided interventions reduce injuries remains scarce.
Conclusions
Wearables should be viewed as monitoring and decision-support tools rather than autonomous injury-prevention systems. Evidence is strongest for measurement and weakens toward injury reduction. Future research should prioritize multicentre validation, causal modelling, standardized reporting, and pragmatic trials.
Alicja Benecka, Iwona Kawka-Bryk, Oliwia Wróblewska et al.· Quality in Sport· 0 citations
Plasma biomarkers offer a transformative, non-invasive approach to early AD diagnosis and primary care triage, reducing reliance on CSF and PET scans and overcoming demographic and methodological limitations is essential for their widespread clinical adoption.
Małgorzata Witaszczyk, Alicja Sołtan, Natalia Wiktorzak et al.· International Journal of Inn...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.